Gene · 4277
Papers3,381
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 3,381
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Combination of 4-1BB and DAP10 promotes proliferation and persistence of NKG2D(bbz) CAR-T cells. | Front Oncol | 2022 | 35965586 | PubTator, text mining | PubMed |
| Revealing the crosstalk between nasopharyngeal carcinoma and immune cells in the tumor microenvironment. | J Exp Clin Cancer Res | 2022 | 35964134 | PubTator, text mining | PubMed |
| Enhanced development of functional human NK cells in NOD-scid-IL2rgnull mice expressing human IL15. | FASEB J | 2022 | 35959876 | PubTator, text mining | PubMed |
| The yin-yang effects of immunity: From monoclonal gammopathy of undetermined significance to multiple myeloma. | Front Immunol | 2022 | 35958625 | PubTator, text mining | PubMed |
| The metabolic addiction of cancer stem cells. | Front Oncol | 2022 | 35957877 | PubTator, text mining | PubMed |
| HIF1, HSF1, and NRF2: Oxidant-Responsive Trio Raising Cellular Defenses and Engaging Immune System. | Chem Res Toxicol | 2022 | 35948068 | PubTator, text mining | PubMed |
| Noncoding RNA-mediated molecular bases of chemotherapy resistance in hepatocellular carcinoma. | Cancer Cell Int | 2022 | 35945536 | PubTator, text mining | PubMed |
| Association of Single-Nucleotide Variants in the Human Leukocyte Antigen and Other Loci With Childhood Hodgkin Lymphoma. | JAMA Netw Open | 2022 | 35939300 | PubTator, text mining | PubMed |
| The MICA-NKG2D axis in clear cell renal cell carcinoma bolsters MICA as target in immuno-oncology. | Oncoimmunology | 2022 | 35936986 | PubTator, text mining | PubMed |
| Evolution and molecular interactions of major histocompatibility complex (MHC)-G, -E and -F genes. | Cell Mol Life Sci | 2022 | 35925520 | PubTator, text mining | PubMed |
| Genome-wide CRISPR screens identify CD48 defining susceptibility to NK cytotoxicity in peripheral T-cell lymphomas. | Blood | 2022 | 35921533 | PubTator, text mining | PubMed |
| Engineering CAR-NK cells: how to tune innate killer cells for cancer immunotherapy. | Immunother Adv | 2022 | 35919494 | PubTator, text mining | PubMed |
| Characterizing intrinsic molecular features of the immune subtypes of salivary mucoepidermoid carcinoma. | Transl Oncol | 2022 | 35917642 | PubTator, text mining | PubMed |
| Revolution of CAR Engineering For Next-Generation Immunotherapy In Solid Tumors. | Front Immunol | 2022 | 35903099 | PubTator, text mining | PubMed |
| Targeting breast cancer with a combination of DNT and LAG3 checkpoint blockage and its mechanism. | Immun Inflamm Dis | 2022 | 35894707 | PubTator, text mining | PubMed |
| Viral Encoded miRNAs in Tumorigenesis: Theranostic Opportunities in Precision Oncology. | Microorganisms | 2022 | 35889167 | PubTator, text mining | PubMed |
| NK Cells and Other Cytotoxic Innate Lymphocytes in Colorectal Cancer Progression and Metastasis. | Int J Mol Sci | 2022 | 35887206 | PubTator, text mining | PubMed |
| Novel Inflammasome-Based Risk Score for Predicting Survival and Efficacy to Immunotherapy in Early-Stage Non-Small Cell Lung Cancer. | Biomedicines | 2022 | 35884843 | PubTator, text mining | PubMed |
| γδ T Cell-Based Adoptive Cell Therapies Against Solid Epithelial Tumors. | Cancer J | 2022 | 35880936 | PubTator, text mining | PubMed |
| γδ T Cells in the Tumor Microenvironment-Interactions With Other Immune Cells. | Front Immunol | 2022 | 35880177 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4277/papers?page=34